Task Force Deep Dive: Affordability & Public-Private Partnership Based on the post-event survey of 2021 AGM, members would like to have deep-dive sessions for functional managers with some task forces. Therefore, the Affordability Task Force and the Public-Private Partnership Task Force is organizing an online deep-dive session with HKAPI members. Subject-matter experts from the task forces […]
Online Deep Dive Session: Drug Enlistment Task Force Based on the post-event survey of 2021 AGM, members would like to have deep-dive sessions for functional managers with some task forces. Therefore, the Drug Enlistment Task Force is organizing an online deep-dive session with HKAPI members. Subject-matter experts from the task forces would share the teams’ […]
The Hong Kong SAR government announced in November 2019 that Hong Kong registered drugs could be used by Hong Kong-owned medical institutions in GBA. We have supported HKU-SZ hospital for the pilot of the policy since then, and GBA Taskforce members have been working hard to work on the details and implementation of the policy […]
The Partnering in Medical Advancement (PMA) task force is working on a Horizon Scanning pilot project with the Department of Pharmacology and Pharmacy, University of Hong Kong. The project aims to build an effective prototype for Horizon Scanning assessment tailor-made for Hong Kong, to help policy makers and payers to have a more forward looking […]
Webinar topics and speakers: The newly announced designated healthcare institution: preparation and expectation in importing HK-registered drugs and medical devices to the GBA - Dr. Michael Li, Pharmacy Manager, Guangzhou United Family Hospital Medical Insurance in the Greater Bay Area - Ms Jamie Zuo, Executive Chairman, Greater Bay Area Healthcare Association Distributor's role and Experience Sharing […]
Topic: Introduction of the first Advanced Therapy Product GMP Facility in Hong Kong Speaker: Dr. Daniel Lee, Associate Vice-President (Innovation and Enterprise), The Chinese University of Hong Kong Language: English Target Audience: Members Only Fee: Free RSVP: Please contact Ms Catherine Chau for more details.
The 54th HKAPI AGM would be held on 30 March 2022.
The HKAPI Medical Representatives’ Training Programme 2022 will be commenced on 7 April 2022 (Thu), the programme information, the schedule and the course rules are enclosed for your perusal. Course Period: 7 April – October 2022 Format: To Be Confirmed (the lectures may be adopted online according to pandemic precautionary measures) Fee of Full course […]
Following the update of the HKAPI Code of Practice at the Annual General Meeting, the Ethics & Compliance Task Force is organizing the Train-the-Trainers Workshop to provide a deep dive into the key changes of the Code and the implications for HKAPI members. The details of the Workshop are as follows: Date: 22 April […]
The HKAPI Medical Representatives’ Training Programme 2022 will be commenced on 7 April 2022 (Thu), the programme information, the schedule and the course rules are as follows Course Period: 7 April – October 2022 Format: To Be Confirmed (the lectures may be adopted online according to pandemic precautionary measures) Fee of Full course and examination: […]
The Regulatory Working Group will kick off an all-year-long survey on Regulatory Intelligence to learn from members the latest practices of local & overseas regulators that may bring systemic impact on the local regulatory requirements and keep members abreast of these updates via regular forums. Before kicking off the survey, the Working Group organizes a […]
We are thrilled to announce the commencement of the HKAPI Medical Representatives Training Programme 2023. This programme has been providing comprehensive training to medical representatives since the 1980s and has already trained more than 2,000 members. The programme will cover a wide range of topics, including pharmaceutical technology, overview of the Hong Kong regulatory and […]
